Cancer Center Community Impact Forum (CCCIF) 2021

What is CCCIF? 

The Cancer Center Community Impact Forum (CCCIF) is a national annual meeting of NCI Designated Cancer Center professionals and professionals at cancer centers working towards designation who hope to impact their catchment areas. This meeting will provide attendees with the opportunity to learn strategies for working on the Cancer Center Support Grant (CCSG) - Community Outreach and Engagement (COE) component, share their expertise, and network with their peers.

What are the goals of CCCIF?

• Create a network of peers doing similar work across the country.
• Provide an opportunity to share programming successes and tips.
• Create a forum to discuss CCSG site visits as it pertains to COE.
• Provide a better understanding of COE structures at cancer centers throughout the country.
• Generate skills to take away from the conference and apply into daily work.

Who should attend CCCIF?

NCI Designated Cancer Center staff and cancer center staff working towards designation whose primary role is working directly with the community to provide education, resources, and support in their defined catchment area. This includes community engagement, community outreach, or cancer disparities (or similar titles) directors, managers, and coordinators as well as faculty conducting research in this space. This is a national conference and we invite applicable staff from across the United States to attend.

To register, click the Register tab above.  Registration for this conference is free. 

By registering for the virtual activity, you will be able to view presentations, hear live audio, and interact online. This virtual activity will be fully web-based, and you will need a computer/laptop or tablet, audio and an internet connection. Details will be emailed to all attendees before the activity. Please be aware that you are not authorized to record, copy or share content in any manner.

Questions?

Contact us at [email protected]

FAQs

I am interested in learning about opportunities to speak at the conference. How do I initiate that process? If you are interested in speaking at the conference, please email [email protected]

Where does this event take place? Due to COVID-19, we have decided to move CCCIF 2021 to be completely virtual. This virtual format will consist of live lectures with audience interaction. Please stay tuned for further information.

Whitney Greene-Nymo, MBA
Executive Director, Program Development, Outreach & Communications, Stanford Cancer Institute
Whitney Greene-Nymo joined the Stanford Cancer Institute (SCI) in 2018 in a newly created and expansive leadership position encompassing reinvigoration and growth of Cancer Health Equity and Community Engagement, strategic communications, event planning, and developing and evolving strategic initiatives connected with clinical partners (e.g. network expansion of clinical trials).  Prior to joining the SCI, Ms. Greene-Nymo spent 9 years at Stanford Health Care (SHC) focused largely on the cancer service line, most recently as the Executive Director of Business Development.  In this role her accomplishments included developing and executing strategies which significantly increased oncology volume and revenue; spearheading SHC’s oncology network development strategy, including the creation of the business plan for Stanford Cancer Center South Bay; and managing the design and construction of the Stanford Women’s Cancer Center.  Ms. Greene-Nymo represents the SCI at a national level having served as a steering committee member of the NCI’s Public Affairs and Marketing Network (PAMN) since 2012.  She served on the 2019 planning committee for the inaugural Cancer Center Community Impact Forum (CCCIF) and has been honored to co-lead the planning efforts for the 2020/2021 CCCIF conference with colleagues from Cedars-Sinai.  Ms. Greene-Nymo earned her MBA from the Stanford Graduate School of Business and a BA in mathematics from Duke University where she was also co-captain of the varsity swimming team.

Zul Surani
Associate Director for Community Outreach and Engagement (COE) for Cedars-Sinai Cancer
Zul Surani is the Associate Director for Community Outreach and Engagement (COE) for Cedars-Sinai Cancer. In this role, he manages all community outreach and engagement for  Cedars-Sinai Cancer and serve as an advisor to investigators and cancer center leadership on catchment area needs to foster research. Zul also serves as the operations director for the Cancer Research Center for Health Equity at Cedars-Sinai Cancer which supports catchment area characterization and research.  He leads a multicultural and intersectional COE team which has launched community outreach programs in the Korean, Filipino, South Asian, Latinx, African American and LGBTQ+ communities in Los Angeles . He has developed a train the trainer navigator program to increase cancer awareness through faith communities and fostered strong collaborations with FQHCs.  In 2019, Zul launched the Clinical Trials Equity Initiative which is focused on addressing barriers that minorities have to accessing cancer clinical trials. Zul’s team manages Community Advisory Boards and networks that inform research, outreach and policy priorities. He has previously worked as  the Executive Director for community partnerships for USC’s Health Sciences Campus and manager for community outreach and engagement for the USC Norris Comprehensive Cancer Center. He served as the Partnership Program Coordinator for NCI’s Cancer Information Service Partnership Program for over a decade and a Community Health Educator for NCI’s National Outreach Network.  Most recently, Zul served as Co-PI on a program to disseminate evidence-based practice to increase lung cancer screening among African Americans in South Los Angeles. Zul studied health care administration, public health and public affairs at USC and is currently pursuing a doctorate in Organizational Change and Leadership also at USC with a focus on implementation and dissemination.

Alyce Adams, PhD
Professor of Epidemiology and Population Health, Stanford University School of Medicine
Associate Director of Cancer Health Equity and Community Engagement, Stanford Cancer Institute
Alyce Adams, PhD was appointed Professor of Epidemiology and Population Health and inaugural Associate Director of Stanford Cancer Institute’s Office of Cancer Health Equity and Community Engagement in February 2021.  Over her nearly 20-year research career, Dr. Adams has established herself as a foremost thought leader in health services and policy research – enhancing understanding of the causes and effects of health care inequities among vulnerable populations. Her research focuses primarily on the determinants of suboptimal use of beneficial health care services among older adults with chronic conditions, including cancer; racial differences in medication adherence; and the impact of health policy changes on access to quality care.

Dr. Adams’ breadth of experience, innovative research, and strategic vision promise to accelerate the impact of the SCI Office of Cancer Health Equity and Community Engagement. This new office, which assumed the mission of SCI’s Community Outreach and Engagement Program, represents a critical investment in Stanford Medicine’s commitment to dismantling the systemic racism that creates barriers to care and results in health inequities.  Faculty and staff in the office promote cancer health equity through bi-directional community partnerships that lead to the co-creation of research, programs, and policies aimed at eliminating cancer health disparities.

Robert T. Croyle, PhD
Director, Division of Cancer Control and Population Sciences, National Cancer Institute
Interim Director, Center for Global Health
Robert Croyle, PhD, was appointed director of the Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), in July 2003.  In this role, he is responsible for overseeing a research portfolio and operating budget of more than a half billion dollars and serves on NCI’s Scientific Program Leaders Committee.  As a division, DCCPS covers a wide range of scientific domains and disciplines, including epidemiology, behavioral science, surveillance and statistics, cancer survivorship, and health services and outcomes research.  He previously served as the division’s associate director for the Behavioral Research Program, leading its development and expansion.  Before coming to NCI in 1998, he was professor of psychology and a member of the Huntsman Cancer Institute at the University of Utah in Salt Lake City. Prior to that, he was a visiting investigator at the Fred Hutchinson Cancer Research Center in Seattle, visiting assistant professor of psychology at the University of Washington, and assistant professor of psychology at Williams College in Massachusetts.

Dr. Croyle received his PhD in social psychology from Princeton University in 1985, and graduated Phi Beta Kappa with a BA in psychology from the University of Washington in 1978.  His research has examined how individuals process, evaluate, and respond to cancer risk information, including tests for inherited mutations in BRCA1 and BRCA2. His research has been published widely in professional journals in behavioral science, public health, and cancer, and he has edited two volumes: Mental Representation in Health and Illness (1991) and Psychosocial Effects of Screening for Disease Prevention and Detection (1995).  He is co-editor of the Handbook of Cancer Control and Behavioral Science (2009) and co-author of Making Data Talk: Communicating Data to The Public, Policy Makers and The Press (2009). He is also co-editor of Strategies for Team Science Success (currently in press).
Dr. Croyle is a member of the Academy of Behavioral Medicine Research, a Fellow of the Society of Behavioral Medicine, a Fellow of the American Psychological Association, and a recipient of several awards for his research and professional service.  His efforts on journal editorial boards include being associate editor for Cancer Epidemiology, Biomarkers and Prevention, and consulting editor for Health Psychology and the British Journal of Health Psychology.  Dr. Croyle received the American Psychological Association (APA) Nathan Perry Career Service to Health Psychology Award in 2009, and an APA Presidential Citation for science and leadership in 2012.  Dr. Croyle received the NIH Merit Award in 1999, 2002 and 2008.  He received the NIH Director’s Award in 2000 and 2015 and the NIH Office of the Director Honor Award in 2013.  In 2014, he received the Distinguished Achievement Award from the American Society of Preventive Oncology.

Electra D. Paskett, Ph.D.,
Marion N. Rowley Professor of Cancer Research and Director
Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine
Professor, Division of Epidemiology, College of Public Health
Associate Director for Population Sciences and Community Outreach, Comprehensive Cancer Center
Director, Center for Cancer Health Equity, Ohio State University
Electra Paskett became the Marion N. Rowley Professor of Cancer Research at The Ohio State University in 2002. She is the Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology in the College of Public Health and the Associate Director for Population Sciences and Community Outreach and Co-Program Leader of the Cancer Control Program in the Comprehensive Cancer Center of the Ohio State University (OSU).  She is also Director of the Center for Cancer Health Equity at the James Cancer Hospital, and immediate past-Chair of the Cancer Control and Health Outcomes Committee of Cancer and Leukemia Group B.  She received her doctorate in epidemiology from the University of Washington.  Dr. Paskett’s 363 peer-reviewed publications showcase her work in intervention research directed at cancer prevention, early detection and survivorship issues. Her studies use multi-level interventions in transdisciplinary teams with community-based participatory research to identify and intervene on factors causing disparities among underserved populations such as social and ethnic minority groups and rural/underserved populations. Dr. Paskett successfully competed for an NCI-funded P50, Center for Population Health and Health Disparities, to examine why rates of cervical cancer are high in Appalachia Ohio and was the Principal Investigator of the Ohio Patient Navigator Research Program.  She also has received funding from the Breast Cancer Research Foundation since 2001.  She continues to work with the Women’s Health Initiative (WHI) and is one of the multiple PI’s of the WHI Cancer Survivor Cohort. Recently, she received funding for a UG3 that is looking at improving colorectal cancer screening through implementation science and a P01 that is looking to improve cervical cancer prevention services in Appalachia. Dr. Paskett was elected as a Fellow to the American Association for the Advancement of Science in 2004. She is a past-President of the American Society of Preventive Oncology, a recent Deputy Editor of the journal Cancer, Epidemiology, Biomarkers & Prevention, and Section Editor of the journal, Cancer. She is Director of the Cancer Control program in Alliance. She also has numerous awards such as the American Society of Preventive Oncology Distinguished Achievement Award, The Alliance for Clinical Trials in Oncology Jimmie Holland Award, the American Association for Cancer Research (AACR) Distinguished Lecture Award on the Science of Cancer Health Disparities and the AACR Team Science Award for her long standing role in the WHI. In 2016, she became a member of the National Cancer Institute’s National Cancer Advisory Board and in 2018 became a member of the National Academies ad hoc Committee on a National Strategy for Cancer Control.

Interested in Sponsoring?

Contact us at [email protected]